Rutgers scholar Nir Eyal is available to discuss the ethics around who will be among the first in line to receive a COVID-19 vaccine when it’s available to the public.
“Unlike other therapy treatments, vaccines help prevent the spread of diseases and should be targeted to people who are more likely to develop the most severe diseases if infected or to people with a high social function who are likely to infect many others,” said Eyal, a Henry Rutgers Professor of Bioethics. “We’d want to vaccinate in high spread areas like jails, meat factories and retirement homes.”
Eyal is also the director of the Center for Population-Level Bioethics in the Department of Health Behavior, Society, and Policy at the Rutgers School of Public Health.
To interview Eyal, contact Maud Alobawone at modesta.alobawone@rutgers.edu or (848) 445-1913.
About RBHS
Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick, and collaborating university-wide, RBHS includes eight schools, a behavioral health network and four centers and institutes. RBHS offers an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research and the full spectrum of allied health careers. RBHS clinical and academic facilities are located throughout the state.
